The Motley Fool

How the Royal Commission helped Insurance Australia Group Ltd (ASX:IAG) score an upgrade

It isn’t easy for companies caught up in the Haynes Royal Commission to find a silver-lining but Insurance Australia Group Ltd (ASX: IAG) may have just gotten lucky!

Its share price jumped an impressive 3.6% to $7.24 when the S&P/ASX 200 (Index:^AXJO) (ASX: XJO) index was flat after Credit Suisse upgraded the stock to a buy on the back of revelations at the Royal Commission.

Ironically, it’s the damning revelations from the Royal Commission that had triggered a big derating in the share prices of financial institutions like Commonwealth Bank of Australia (ASX: CBA), National Australia Bank Ltd. (ASX: NAB) and AMP Limited (ASX: AMP).

IAG was also swept up in the probe with its share price slumping 13% in the past three months before Thursday’s rally but the pain may have been worth it.

Credit Suisse had been puzzled by the insurer’s shrinking underlying insurance margin for its commercial lines despite two years of premium rate increases.

The broker’s inability to account for the margin squeeze is a key reason why it had a “neutral” rating on the stock.

“Due to the abundance of commercially-sensitive information that is being provided by the Royal Commission, we can now see that a large reason for this has been the exit of the Swann business,” said Credit Suisse.

“While IAG reported an underlying margin decline of 280bp [basis points] in its Australia Business division in FY17 and a further 30bp decline in FY18, excluding the impact of the Swann divestments, we estimate the decline to be 90bp in FY17 and an expansion of 50bp in FY18.”

Now that the broker can explain the margin movement, it is more confident that management can meet or even exceed its FY19 margin forecast and has upgraded its recommendation on the stock to “outperform”.

If that isn’t enough to get investors excited, Credit Suisse estimates that IAG will have a further $600 million to splash on shareholders. This could come in the form of a $300 million special dividend and $300 million share buyback.

“While IAG has been the best performing insurance stock in the past 12 months (+13% TSR above ASX200), the stock has pulled back in the last four months which we don’t see as justified,” said Credit Suisse.

“The pullback provides an opportunity to buy a high-quality company at an attractive entry point.”

The broker has a $7.90 price target on the stock.

If you are looking for other blue-chip buying opportunities, the experts at the Motley Fool have some good news for you.

They’ve picked their favourite blue-chip stocks for FY19 and you can find out what they are by following the free link below.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Brendon Lau owns shares of National Australia Bank Limited. The Motley Fool Australia owns shares of Insurance Australia Group Limited and National Australia Bank Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

One ASX Stock For An Estimated $US22 Billion Marijuana Market

A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

And make no mistake – it is coming. To the tune of an estimated $US22 billion.

Cannabis legalisation is sweeping over North America, and full legalisation arrived in Canada in October 2018.

Here’s the best part: we think there’s one ASX stock that’s uniquely positioned to profit immensely from this explosive new industry… taking savvy investors along for what could be one heck of a ride.

AND, this is the first time The Motley Fool Australia has EVER put a BUY recommendation on a marijuana stock.

Simply click below to learn more on how you can profit from the coming cannabis boom.

Click here to find out more